PMID- 29064194
OWN - NLM
STAT- MEDLINE
DCOM- 20190329
LR  - 20190329
IS  - 1660-9379 (Print)
IS  - 1660-9379 (Linking)
VI  - 13
IP  - 579
DP  - 2017 Oct 18
TI  - [Proton pump inhibitors overprescription].
PG  - 1782-1786
AB  - Overutilization of proton pump inhibitors (PPI) is obvious despite available 
      recommendations, with clinical and economical issues. This overuse is due to 
      abusive stress ulcer prophylaxis and to automatic represcription, particularly 
      during transitions from intensive care unit to other inhospital units and at 
      hospital discharge. Withdrawal symptoms may contribute to the difficulty of PPI 
      interruption. It is mandatory to limit initiation of PPI treatment outside of 
      appropriate indications and to regularly reassess the need of this treatment.
FAU - Esteves, Marie
AU  - Esteves M
AD  - Service de medecine interne generale, Departement de medecine interne, 
      rehabilitation et geriatrie, HUG, 1211 Geneve 14.
FAU - Rollason, Victoria
AU  - Rollason V
AD  - Service de pharmacologie et toxicologie cliniques, HUG, 1211 Geneve 14.
FAU - Grosgurin, Olivier
AU  - Grosgurin O
AD  - Service de medecine interne generale, Departement de medecine interne, 
      rehabilitation et geriatrie, HUG, 1211 Geneve 14.
LA  - fre
PT  - Journal Article
TT  - Surprescription des inhibiteurs de la pompe a protons.
PL  - Switzerland
TA  - Rev Med Suisse
JT  - Revue medicale suisse
JID - 101219148
RN  - 0 (Proton Pump Inhibitors)
SB  - IM
MH  - Humans
MH  - *Inappropriate Prescribing
MH  - Intensive Care Units
MH  - Patient Discharge
MH  - *Proton Pump Inhibitors/therapeutic use
MH  - *Stomach Ulcer/drug therapy
COIS- Les auteurs n'ont declare aucun conflit d'interets en relation avec cet article.
EDAT- 2017/10/25 06:00
MHDA- 2019/03/30 06:00
CRDT- 2017/10/25 06:00
PHST- 2017/10/25 06:00 [entrez]
PHST- 2017/10/25 06:00 [pubmed]
PHST- 2019/03/30 06:00 [medline]
PST - ppublish
SO  - Rev Med Suisse. 2017 Oct 18;13(579):1782-1786.